Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Skip to content
Jeff Baxter
Ottawa biotech lab gets $56M shot in the arm for COVID vaccine research
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
Budget-Friendly Tips for Buying a Home in Ottawa
Musfiqur Rahman
OGC Design + Build: Client Reviews Helped Boost Business
Nick Karrandjas
